chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The first Dose was administered on March 31.  I started staining then bleeding several days after which is not normally a part of my menstrual cycle.  This continued for several days and times up until the second dose on April 21.  I started bleeding again on April 27 which was not my predicted normal menstrual start date. Immediately after the second dose on April 21st I had a sharp shooting pain in my neck and left arm.  I waited at the hospital for 30 minutes and no further reaction so I left.  On the car ride home I started to get a headache which has continued almost daily since that date.  I started to get a pin and needles sensation in my face and fingers about 1 hour after the dose which I assumed was a panic attack.  The pins and needles and then slight numbness continued on and off in my face, forearms, hands, fingers, knees, shins, feet, and toes.  Still experiencing this today (5/23/21).  At Approx 6:30pm on April 21st I began to feel very fatigued.  Head was pounding and I started to feel chills.  Head to toe Body aches shortly followed and then 101.6 fever kicked in.  Body aches and fever lasted for 2.5 days.   On April 23 my fever broke. Still in bed from April 21, I was then woken by severe stomach pains.  I started vomiting and having diarrhea at the same time.  This lasted a few hours. I lost 3 pounds in the first few days following my 2nd dose
5 minutes after administering DTP, MMR and PPD child developed generalized urticarial rash that resolved spontaneously in 15 min. No SOB. No itching or other symptoms.
On 5/10/00, pt noticed a lump on bottom of left foot. On 6/18/00, he noticed bumps on head, under skin surface, bumps on bottoms of both feet with swelling and redness on feet and arms. Seemed to last 2 to 4 days.
Site: Swelling at Injection Site-Severe, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: patient reports on right arm had swelling as well as right side of face : cheeks, eyes will go to see urgent care
Pt recvd 3 doses of Engerix B; a/titer was checked pt died as a result of pancreatic cancer; dx p/completion of vax series; cancer & subsequent death were considered not related to vax series;
Patient received Moderna dose 1 and 2 at age 17, which is an unauthorized age group.
Injection site on left deltoid area swollen like a golf-ball size. Area red and warm to touch. Left arm pain, numbness extending down to fingers. Difficulty in moving arm.  The following day 09/13/2010- body aches with very low energy ... felt exhausted. Continued to feel tired but body aches improved.  Then on 09/22/2010 in the evening started with sore throat .. which seemed to improve slightly on the 09/24/2010.  On 09/25/2010 had to leave work early due to not feeling well.  Sore throat severe body ache and fever which got worse .. severe reaction.. this continued until 09/28/2010 fever and body ache resolved however, very low energy level still persists up until today.
Raised, red, and painful at the injection site. Also reports a "strange sensation" that moved into her head. Took a week or two weeks to completely heal. Patient reports back to the pharmacy today to report that they now have shingles and is taking VALTREX to remedy this.
got the shingles shot / broke out on both sides/suspected vaccination failure; broke out on both sides; it hurt; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient got the Shingles shot then he/she broke out on both sides around mid-section. The patient informed that it hurt. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Narrative:  acute sensorineural hearing loss one day after Covid 3 vaccine He has been evaluated by ENT and treated with steroids, course finished tomorrow. pt requesting Audiology referral
Breakthrough case admission after two vaccines Pfizer 3/9/21 Lot# EN6205;  Pfizer 3/30/21 Lot# EN6208
approx 15 minutes after flu shot administration I initially felt increasingly disorientated, brief nausea and then I went blind. I felt as if I was separated from my body! I was semi-conscious and totally paralysed (lucky I was sitting down). I struggled for air as felt extremely hot and sweat. I was completely recovered after 15 minutes! I thought I was having an allergic reaction which in turn made me panic so I'm not sure as to whether or not this reaction was a panic attack or an alegic reaction as the symptoms are similar. I need to know so that I don't receive the flu shot again if I am allergic.
Severe dehydration with dark urine, muscle/joint pain, head ache, chills
A Pharmacy technician gave a Moderna as a second dose Pfizer to a 16 year old. The mother and child remained in store for 30 minutes before leaving and nothing had happened at that point. I called "Immunization Specialist"  and he said to call mother and tell her that this type of accident has happened before and she will need to bring kids back in 28 days for a second dose Moderna shot.
Arm on the injection site became red; Swollen/ getting bigger; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Arm on the injection site became red) and INJECTION SITE SWELLING (Swollen/ getting bigger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT), ALPRAZOLAM (XANAX), SECUKINUMAB (COSENTYX), MULTIVITAMIN [VITAMINS NOS] and VITAMIN D NOS for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Arm on the injection site became red) and INJECTION SITE SWELLING (Swollen/ getting bigger). At the time of the report, INJECTION SITE ERYTHEMA (Arm on the injection site became red) and INJECTION SITE SWELLING (Swollen/ getting bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information provided was patient took diphenhydramine.
Myalgia, Arthralgia, right arm pain worsening Narrative: worsening arm pain referred for physical therapy and ortho consult
Patient developed red spots on her right leg, back and arms. Doesn't bother her. Not itchy. No fevers, irritability.
Breakthrough case admission after 2 vaccines Moderna 2/10/21 Lot# 015M20A;  Moderna 3/10/21 Lot# 030A21A
pt c/o h/a a/vax;approx 1hr p/vax the h/a became worse;nausea occurred & face started to swell;mom called clinic & brought pt in to be checked;pt examined by MD no swelling noted;told to take DPH TID:
Pt light headed and dizzy. Same symptoms with first dose. She has a history per patient of vestibular fainant.
In addition to fevers, headaches, body aches, chills, and joint pain, I developed muscle spasms in my hamstrings and calf muscles. Three days later I still have tendonitis symptoms and some hip joint pain. I developed a large erythemic swelling at the site of inoculation and a rash which is about 6 inches in length by 4 inches in width.
Hospitalized 1/3/2022-1/3/2022 Covid + 12/29/21; presented for increased weakness, fatigue; UTI w/severe sepsis w/o shock, acute respiratory failure
Patient returned to clinic 2 days following immunization with pain, redness and swelling at immunization site.  Diagnosed with cellulitis and given antibiotics.
Drug ineffective/Symptoms including running nose and fever; COVID-19/Symptoms including running nose and fever; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in Oct2022 as dose 4 (booster), single (Lot number: GJ6665) at the age of 40 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: COVID-19 (medically significant) with onset 29Jun2023, outcome "not recovered", described as "COVID-19/Symptoms including running nose and fever"; DRUG INEFFECTIVE (medically significant) with onset 29Jun2023, outcome "not recovered", described as "Drug ineffective/Symptoms including running nose and fever". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: negative test after treatment; Positive, notes: positive antigen test five days post negative test after treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: Patient had no known allergies, had no other medication in 2 weeks.   No follow-up attempts are possible. No further information is expected.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021 at 11:08 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 22-Jun-2021 at 11:08 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 55.80  Concomitant products were not provided.  On 22-Jun-2021, Excursion time were at 08 AM was 35, total doses given for the day was 36 , condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 27-May-2021, vial was moved to clinic on 22-Jun-2021. 4 vials was moved to clinic. Vaccine BUD date was 26-Jun-2021.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree F.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. Temperature recordings were taken by using a traceable temperature monitor at every hour. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.
No further AE; temperature excursion; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 27-AUG-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, lot # R025726, expiration date: 26-MAY-2021 (injection site and route of administration were not provided) for prophylaxis.  On 04-AUG-2020, the administered dose experienced the temperature excursions of below 2 degrees Celsius (C) (1.1 C) for 27 hours and 45 minutes and above 9 degrees Celsius (9 C) for 1 hour and 15 minutes. The digital data logger was involved. No previous temperature excursion had occurred. No further adverse events (AE) were reported.  This is one of multiple reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.devicelotnumber: R025726; expirationdate: 26-MAY-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:Same Reporter
Sore arm; Sleepy; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the left arm on 03Apr2021 at 08:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history, concomitant medications and allergic history were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 03Apr2021 at 18:00, the patient experienced sore arm and felt sleepy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events sore arm and sleepy was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Daughter called to report that her mother passed away on 5/26/2022 and wanted to provide some information because she has gotten her Moderna booster 6 days prior to her passing. She is not use the death was related to the vaccine administration but wanted to report it anyway. She stated her mother received her first Moderna booster on 11/21/21 and on 11/24/21 she has a varicose vein rupture and she was seen in the ER and released. This vaccine is not listed in the system. Her daughter then reported she got her 2nd Moderna booster at the local County Health Department on 5/19/2022 and on 5/22/2022 had severe abdominal pain and was sent to the hospital and diagnosed with an aortic dissection and place on comfort care and she passed on 5/26/2022. Her daughter was reporting in case it could have been due to the Moderna vaccine.
Itchy rash on upper back, posterior neck and anterior chest began 3 hours after injection
Chest pains began one day after the vaccine and continued to worsen. The morning of the third day after the vaccine, chest pain became so strong that I went to the emergency room. I spent 3 days and 2 nights in the ICU.
Patient received first Covid Moderna vaccination on 4/5/21 and on Thursday 4/8/21 was admitted to the hospital with a pulmonary embolism. She was released and put on Eliquis.  The patient has been unable to reach via phone.
This spontaneous report as received from a medical assistant refers to an unspecified number of patient of unknown age and gender. No information regarding the patients' medical history, concurrent conditions and concomitant medications was provided. The patients were vaccinated with the doses of RECOMBIVAX HB injection, lot # L003193 with expiration date 10-NOV-2016 and lot# reported as L038499 with expiration date 26-JUN-2017 (dose and route of administration were not reported), which were exposed to temperature outside of the recommended range for much longer than originally realized, and had been administered to the patients since these excursions began to occur on an unspecified date in July 2015. The refrigerator, in which the vaccine was stored, had been "losing power" each night for 8 hours since an unspecified date in July, 2015. The vaccines was exposed to temperatures as high as 65 Fahrenheit (F) as long as 8 hours each night since an unspecified date in July, 2015. The reporter's facility started to use a data logger, which was how the daily (also reported as each night) power interruption was discovered. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
Three days after receiving dose #1 of HPV vaccine, she broke out with hives on her back.  These went away, but then she broke out again with hives on 11/6/07 on back and abdomen.  Subsided on own within a day.
Less than 50 pustules on face, neck, trunk, arms, legs, no fever. ER visit 3/11/2015, no labs performed, dx. by ER Dr. made per S&S, mother used Caladryl lotion.
Information has been received from a physician concerning a patient who in February 2007 and approximately 23-APR-2007 was vaccinated with the first and second doses of oral rotavirus vaccine (human-bovine), respectively. on 23-APR-2007, within 24 hours, of vaccination, the patient developed severe diarrhea. It was also reported the patient developed this same symptom after receiving the first dose of vaccine in February. Subsequently, the patient was recovering from the severe diarrhea. Unspecified medical attention was sought. Additional information has been requested.
A nurse reported the occurrence of limb swelling in a child of unspecified age and gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. The subject's medical history, concurrent conditions, and concurrent medications were not reported. In April 2003 or May 2003, the subject received the fifth injection of Infanrix (lot DTPA592A9). At an unspecified time post-immunization, the subject developed limb swelling and an injection site reaction characterized by redness and pain. The reporting nurse thought this vaccine may not have been stored properly prior to delivery to her. As of 5/5/03, the events persisted. Comment: The reporting nurse indicated that 36 children experienced these same events following receipt of Infanrix lot DTPA592A9. The subject's received the third, fourth, or fifth injection in the immunization series. However, they are not presently identifiable.
I don't know the brand of covid vaccine.  Forced by this format to select, I chose Pfizer because that is what her other two vaccines were.   Patient told me they required her to get the booster because there had been a covid case at the facility.
Pt has had 8 days of fatigue, decreased appetite and fluid intake, cough and shortness of breath.  Pt was admitted for acute hypoxic respiratory failure secondary to COVID pneumonia.
My 13 year old son had the HPV vaccine at the doctor's office around 9am. When he went to football practice at 6, he became very winded, tingling in feet and hands, dizzy, and had goosebumps very bad! He drinks water throughout the day and he has a peanut butter and jelly sandwich before practice. I did report this reaction to his doctor.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Hypertension-Medium, Systemic: Tachycardia-Medium
her Husband who had COVID at that time; her Husband who had COVID at that time; This is a spontaneous report from a contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunisation. Medical history included Type 2 Diabetic from 1995. The patient's concomitant medications were not reported. The reporter suspected that she was infected by her husband who had COVID at that time. While reporting adverse event for herself, she mentioned that her husband also was positive for the COVID virus after receiving the COVID vaccine. She mentioned that her husband was healthier than her that's why he got the 2nd dose 6 and a half weeks after the 1st one. Outcome of the event was unknown.  Information on the lot/batch number has been requested.
Swollen lymph nodes on left side in the midclavicular region. Lymph nodes are each about the size of grapes. It has been over two weeks since my vaccine and the size has not decreased. No other symptoms other than pain at the injection site for the first 2 days.
This spontaneous report as received from a nurse refers to an unspecified patient. On 26-JUN-2013 the patient was vaccinated with PROQUAD (lot # reported as J001011, expire date 28-JUL-2014), injection that went through a temperature excursion that was not supported. No adverse effect reported. Additional information has been requested.
"not feeling great"; headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION ("not feeling great") and HEADACHE (headaches) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION ("not feeling great") and HEADACHE (headaches). The patient was treated with LOSARTAN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION ("not feeling great") and HEADACHE (headaches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) increased.         Sometime in April the patient stopped taking losartan and he said he was feeling fine.